Helin Zhang
Lanzhou, 730000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer.
Journal: Cellular signalling
Published: February 26, 2026
Commentary: Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: insights from NHANES.
Journal: Frontiers in immunology
Published: January 29, 2026
TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review.
Journal: Cancers
Published: December 24, 2025
CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues.
Journal: American journal of cancer research
Published: October 05, 2025
A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma.
A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma.
Journal: Translational andrology and urology
Published: August 21, 2025
Comment on "Innovative logic 'AND' gate gene circuits for bladder cancer treatment: preclinical study".
Journal: International journal of surgery (London, England)
Published: July 03, 2025
High FSTL1 expression promotes bladder cancer progression by enhancing tumor cell migration.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 24, 2025
Short-term high-dose gemcitabine induces PERK-mediated immunogenic cell death and potentiates antitumor immunity in bladder cancer.
Journal: International immunopharmacology
Published: March 27, 2025
Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: February 16, 2025
Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
Journal: Molecular biotechnology
Published: January 05, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026